Do analysts rate CERS or UTMD?

Cerus presently has a consensus price target of $4.00, suggesting a potential upside of 88.24%. Given Cerus' stronger consensus rating and higher probable upside, research analysts clearly believe Cerus is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media refer more to CERS or UTMD?

In the previous week, Cerus had 7 more articles in the media than Utah Medical Products. MarketBeat recorded 8 mentions for Cerus and 1 mentions for Utah Medical Products. Cerus' average media sentiment score of 0.48 beat Utah Medical Products' score of -0.13 indicating that Cerus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cerus 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Utah Medical Products 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend OSUR or UTMD?

OraSure Technologies currently has a consensus target price of $3.00, suggesting a potential downside of 27.26%. Given OraSure Technologies' higher possible upside, research analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor OSUR or UTMD?

In the previous week, OraSure Technologies had 2 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for OraSure Technologies and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of -0.13 beat OraSure Technologies' score of -0.25 indicating that Utah Medical Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Utah Medical Products 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate ANIK or UTMD?

Anika Therapeutics currently has a consensus target price of $21.00, indicating a potential upside of 7.94%. Given Anika Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Anika Therapeutics is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anika Therapeutics 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor ANIK or UTMD?

In the previous week, Anika Therapeutics had 15 more articles in the media than Utah Medical Products. MarketBeat recorded 16 mentions for Anika Therapeutics and 1 mentions for Utah Medical Products. Anika Therapeutics' average media sentiment score of 0.56 beat Utah Medical Products' score of -0.13 indicating that Anika Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anika Therapeutics 4 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Utah Medical Products 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend UTMD or WST?

West Pharmaceutical Services has a consensus price target of $368.08, indicating a potential upside of 5.81%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 West Pharmaceutical Services 0 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 2 Strong Buy rating(s) 3.00

Do analysts recommend COO or UTMD?

Cooper Companies presently has a consensus target price of $81.36, suggesting a potential upside of 9.42%. Given Cooper Companies' stronger consensus rating and higher probable upside, research analysts plainly believe Cooper Companies is more favorable than Utah Medical Products. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cooper Companies 3 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.35 Utah Medical Products 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor COO or UTMD?

In the previous week, Cooper Companies had 16 more articles in the media than Utah Medical Products. MarketBeat recorded 17 mentions for Cooper Companies and 1 mentions for Utah Medical Products. Cooper Companies' average media sentiment score of 0.91 beat Utah Medical Products' score of -0.13 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 9 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Utah Medical Products 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Utah Medical Products (UTMD) Competitors

$72.55 -0.20 (-0.28%)

As of 02:56 PM Eastern

Compare

UTMD vs. CERS, OSUR, ANIK, WST, and COO

Should you buy Utah Medical Products stock or one of its competitors? MarketBeat compares Utah Medical Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Cooper Companies (COO).

How does Utah Medical Products compare to Cerus?

Cerus (NASDAQ:CERS) and Utah Medical Products (NASDAQ:UTMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Utah Medical Products has lower revenue, but higher earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerus	$206.13M	2.08	-$15.63M	-$0.03	N/A
Utah Medical Products	$38.52M	5.99	$11.29M	$3.28	22.12

Cerus presently has a consensus price target of $4.00, suggesting a potential upside of 88.24%. Given Cerus' stronger consensus rating and higher probable upside, research analysts clearly believe Cerus is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerus	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Cerus had 7 more articles in the media than Utah Medical Products. MarketBeat recorded 8 mentions for Cerus and 1 mentions for Utah Medical Products. Cerus' average media sentiment score of 0.48 beat Utah Medical Products' score of -0.13 indicating that Cerus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cerus	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Utah Medical Products	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Utah Medical Products has a net margin of 29.04% compared to Cerus' net margin of -3.06%. Utah Medical Products' return on equity of 8.79% beat Cerus' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cerus	-3.06%	-10.19%	-3.14%
Utah Medical Products	29.04%	8.79%	8.53%

78.4% of Cerus shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 5.3% of Cerus shares are held by insiders. Comparatively, 8.0% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cerus has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.35, suggesting that its share price is 65% less volatile than the broader market.

Summary

Cerus and Utah Medical Products tied by winning 8 of the 16 factors compared between the two stocks.

How does Utah Medical Products compare to OraSure Technologies?

OraSure Technologies (NASDAQ:OSUR) and Utah Medical Products (NASDAQ:UTMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

OraSure Technologies currently has a consensus target price of $3.00, suggesting a potential downside of 27.26%. Given OraSure Technologies' higher possible upside, research analysts clearly believe OraSure Technologies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OraSure Technologies	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, OraSure Technologies had 2 more articles in the media than Utah Medical Products. MarketBeat recorded 3 mentions for OraSure Technologies and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of -0.13 beat OraSure Technologies' score of -0.25 indicating that Utah Medical Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OraSure Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Utah Medical Products	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 4.7% of OraSure Technologies shares are held by company insiders. Comparatively, 8.0% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Utah Medical Products has a net margin of 29.04% compared to OraSure Technologies' net margin of -66.42%. Utah Medical Products' return on equity of 8.79% beat OraSure Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OraSure Technologies	-66.42%	-18.57%	-15.71%
Utah Medical Products	29.04%	8.79%	8.53%

OraSure Technologies has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.Comparatively, Utah Medical Products has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market.

Utah Medical Products has lower revenue, but higher earnings than OraSure Technologies. OraSure Technologies is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OraSure Technologies	$115.02M	2.47	-$68.73M	-$1.04	N/A
Utah Medical Products	$38.52M	5.99	$11.29M	$3.28	22.12

Summary

Utah Medical Products beats OraSure Technologies on 10 of the 15 factors compared between the two stocks.

How does Utah Medical Products compare to Anika Therapeutics?

Anika Therapeutics (NASDAQ:ANIK) and Utah Medical Products (NASDAQ:UTMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership and profitability.

Anika Therapeutics has a beta of 0.23, indicating that its share price is 77% less volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market.

Anika Therapeutics currently has a consensus target price of $21.00, indicating a potential upside of 7.94%. Given Anika Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe Anika Therapeutics is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anika Therapeutics	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Anika Therapeutics had 15 more articles in the media than Utah Medical Products. MarketBeat recorded 16 mentions for Anika Therapeutics and 1 mentions for Utah Medical Products. Anika Therapeutics' average media sentiment score of 0.56 beat Utah Medical Products' score of -0.13 indicating that Anika Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anika Therapeutics	4 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Utah Medical Products	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Utah Medical Products has lower revenue, but higher earnings than Anika Therapeutics. Anika Therapeutics is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anika Therapeutics	$120.65M	2.16	-$10.88M	-$0.27	N/A
Utah Medical Products	$38.52M	5.99	$11.29M	$3.28	22.12

91.5% of Anika Therapeutics shares are held by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are held by institutional investors. 12.1% of Anika Therapeutics shares are held by company insiders. Comparatively, 8.0% of Utah Medical Products shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Utah Medical Products has a net margin of 29.04% compared to Anika Therapeutics' net margin of -3.14%. Utah Medical Products' return on equity of 8.79% beat Anika Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anika Therapeutics	-3.14%	0.20%	0.15%
Utah Medical Products	29.04%	8.79%	8.53%

Summary

Anika Therapeutics and Utah Medical Products tied by winning 8 of the 16 factors compared between the two stocks.

How does Utah Medical Products compare to West Pharmaceutical Services?

Utah Medical Products (NASDAQ:UTMD) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

In the previous week, West Pharmaceutical Services had 10 more articles in the media than Utah Medical Products. MarketBeat recorded 11 mentions for West Pharmaceutical Services and 1 mentions for Utah Medical Products. West Pharmaceutical Services' average media sentiment score of 1.63 beat Utah Medical Products' score of -0.13 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Utah Medical Products	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
West Pharmaceutical Services	10 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

West Pharmaceutical Services has a consensus price target of $368.08, indicating a potential upside of 5.81%. Given West Pharmaceutical Services' stronger consensus rating and higher probable upside, analysts clearly believe West Pharmaceutical Services is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
West Pharmaceutical Services	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00

Utah Medical Products has a net margin of 29.04% compared to West Pharmaceutical Services' net margin of 16.98%. West Pharmaceutical Services' return on equity of 20.11% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Utah Medical Products	29.04%	8.79%	8.53%
West Pharmaceutical Services	16.98%	20.11%	14.83%

Utah Medical Products has a beta of 0.35, indicating that its share price is 65% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market.

West Pharmaceutical Services has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Utah Medical Products	$38.52M	5.99	$11.29M	$3.28	22.12
West Pharmaceutical Services	$3.07B	7.96	$493.70M	$7.81	44.54

Utah Medical Products pays an annual dividend of $1.24 per share and has a dividend yield of 1.7%. West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Utah Medical Products pays out 37.8% of its earnings in the form of a dividend. West Pharmaceutical Services pays out 11.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Utah Medical Products has increased its dividend for 3 consecutive years. Utah Medical Products is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

West Pharmaceutical Services beats Utah Medical Products on 16 of the 20 factors compared between the two stocks.

How does Utah Medical Products compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and Utah Medical Products (NASDAQ:UTMD) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

Cooper Companies has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	3.54	$374.90M	$1.18	63.01
Utah Medical Products	$38.52M	5.99	$11.29M	$3.28	22.12

In the previous week, Cooper Companies had 16 more articles in the media than Utah Medical Products. MarketBeat recorded 17 mentions for Cooper Companies and 1 mentions for Utah Medical Products. Cooper Companies' average media sentiment score of 0.91 beat Utah Medical Products' score of -0.13 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	9 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Utah Medical Products	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 8.0% of Utah Medical Products shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies presently has a consensus target price of $81.36, suggesting a potential upside of 9.42%. Given Cooper Companies' stronger consensus rating and higher probable upside, research analysts plainly believe Cooper Companies is more favorable than Utah Medical Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Utah Medical Products	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Utah Medical Products has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market.

Utah Medical Products has a net margin of 29.04% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Utah Medical Products' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Utah Medical Products	29.04%	8.79%	8.53%

Summary

Cooper Companies beats Utah Medical Products on 11 of the 17 factors compared between the two stocks.

Get Utah Medical Products News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UTMD vs. The Competition

Export

Metric	Utah Medical Products	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$229.22M	$5.70B	$6.80B	$13.01B
Dividend Yield	1.76%	1.78%	2.60%	10.03%
P/E Ratio	21.98	23.54	279.98	25.51
Price / Sales	5.99	59.23	649.35	116.02
Price / Cash	15.81	32.53	28.64	34.82
Price / Book	1.95	6.50	11.15	6.35
Net Income	$11.29M	$151.72M	$3.48B	$347.60M
7 Day Performance	2.24%	6.11%	2.51%	3.14%
1 Month Performance	-0.32%	0.89%	-2.78%	-2.08%
1 Year Performance	27.77%	9.82%	64.32%	21.27%

Utah Medical Products Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UTMD Utah Medical Products	1.2983 of 5 stars	$72.55 -0.3%	N/A	+32.4%	$229.22M	$38.52M	21.98	180	News Coverage
CERS Cerus	2.3746 of 5 stars	$2.92 -4.9%	$4.00 +37.0%	+69.3%	$615.13M	$206.13M	N/A	290	Earnings Report
OSUR OraSure Technologies	1.1048 of 5 stars	$4.02 +1.5%	$3.00 -25.4%	+38.2%	$272.64M	$115.02M	N/A	840	Upcoming Earnings Analyst Downgrade
ANIK Anika Therapeutics	1.9103 of 5 stars	$15.15 +0.9%	$17.00 +12.2%	+140.0%	$199.86M	$116.26M	N/A	300	Earnings Report Analyst Upgrade
WST West Pharmaceutical Services	3.9943 of 5 stars	$337.46 +1.9%	$364.42 +8.0%	+45.4%	$23.31B	$3.07B	43.21	10,800	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UTMD) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and COO

How does Utah Medical Products compare to Cerus?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Summary

How does Utah Medical Products compare to Cooper Companies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Utah Medical Products (UTMD) Competitors

UTMD vs. CERS, OSUR, ANIK, WST, and COO

How does Utah Medical Products compare to Cerus?

Which has stronger valuation and earnings, CERS or UTMD?

Do analysts rate CERS or UTMD?

Does the media refer more to CERS or UTMD?

Is CERS or UTMD more profitable?

Do institutionals & insiders have more ownership in CERS or UTMD?

Which has more risk & volatility, CERS or UTMD?

Summary

How does Utah Medical Products compare to OraSure Technologies?

Do analysts recommend OSUR or UTMD?

Does the media favor OSUR or UTMD?

Do institutionals and insiders have more ownership in OSUR or UTMD?

Is OSUR or UTMD more profitable?

Which has more risk & volatility, OSUR or UTMD?

Which has stronger earnings and valuation, OSUR or UTMD?

Summary

How does Utah Medical Products compare to Anika Therapeutics?

Which has more volatility and risk, ANIK or UTMD?

Do analysts rate ANIK or UTMD?

Does the media favor ANIK or UTMD?

Which has preferable earnings and valuation, ANIK or UTMD?

Do institutionals & insiders hold more shares of ANIK or UTMD?

Is ANIK or UTMD more profitable?

Summary

How does Utah Medical Products compare to West Pharmaceutical Services?

Does the media refer more to UTMD or WST?

Do insiders and institutionals hold more shares of UTMD or WST?

Do analysts recommend UTMD or WST?

Is UTMD or WST more profitable?

Which has more volatility & risk, UTMD or WST?

Which has stronger valuation & earnings, UTMD or WST?

Is UTMD or WST a better dividend stock?

Summary

How does Utah Medical Products compare to Cooper Companies?

Which has higher earnings and valuation, COO or UTMD?

Does the media favor COO or UTMD?

Do institutionals and insiders hold more shares of COO or UTMD?

Do analysts recommend COO or UTMD?

Which has more risk & volatility, COO or UTMD?

Is COO or UTMD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UTMD vs. The Competition

Utah Medical Products Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools